Patents by Inventor Michelle L. Guaragno

Michelle L. Guaragno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMIMETIC DRUG DELIVERY OF AN IMMUNOMODULATORY AGENT FOR THE TREATMENT OF OCULAR CONDITIONS
    Publication number: 20220296716
    Abstract: A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent loaded-carrier provides controlled delivery of the therapeutic agent under conditions suitable for recruiting regulatory T cells to an ocular region of interest or inducing regulatory T cells in an ocular region of interest.
    Type: Application
    Filed: June 7, 2022
    Publication date: September 22, 2022
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Steven R. Little, Michelle L. Guaragno, Andrew J. Glowacki, Morgan V. Fedorchak, Stephen C. Balmert
  • Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions
    Patent number: 11395853
    Abstract: A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent loaded-carrier provides controlled delivery of the therapeutic agent under conditions suitable for recruiting regulatory T cells to an ocular region of interest or inducing regulatory T cells in an ocular region of interest.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: July 26, 2022
    Assignee: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Steven R. Little, Michelle L. Guaragno, Andrew J. Glowacki, Morgan V. Fedorchak, Stephen C. Balmert
  • BIOMIMETIC DRUG DELIVERY OF AN IMMUNOMODULATORY AGENT FOR THE TREATMENT OF OCULAR CONDITIONS
    Publication number: 20170367981
    Abstract: A method for treating an ocular disorder in a subject comprising administering a therapeutic agent-loaded carrier to an ocular site of the subject in need thereof, wherein the therapeutic agent loaded-carrier provides controlled delivery of the therapeutic agent under conditions suitable for recruiting regulatory T cells to an ocular region of interest or inducing regulatory T cells in an ocular region of interest.
    Type: Application
    Filed: June 20, 2017
    Publication date: December 28, 2017
    Applicant: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Steven R. Little, Michelle L. Guaragno, Andrew J. Glowacki, Morgan V. Fedorchak, Stephen C. Balmert